NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Critical Illness Myopathy
Interventions
DEVICE

Motomed Letto® servo-assisted cycling + standard physiotherapy

Servo-assisted cycling using the Motomed Letto® device with a cadence target of 30 revolutions per minute (rpm), performed for 60 minutes twice daily for 7 days. This intervention is administered in addition to standard ICU physiotherapy to critically ill patients at risk of critical illness myopathy (CIM).

BEHAVIORAL

Standard physiotherapy

Standard physiotherapy including mobilization and passive/active range-of-motion exercises, delivered during routine ICU care for 7 days.

Trial Locations (3)

7520440

Clínica INDISA, Santiago

8330075

Hospital de Urgencia Asistencia Pública (HUAP), Santiago

8380453

University of Chile, Santiago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Clinica Indisa

OTHER

collaborator

Hospital de Urgencia y Asistencia Pública

UNKNOWN

lead

University of Chile

OTHER

NCT07017517 - NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness | Biotech Hunter | Biotech Hunter